Today we published our first NIH UNITE Progress Report! Covering Fiscal Years 2021–2022, the UNITE Progress Report describes NIH’s actions to identify and address structural racism that may exist within the NIH and in the biomedical and behavioral research enterprise.
We looked at applications broken down by career stage in June 2022. It was interesting to notice slowly increasing trends in the proportions of early stage investigator applications submitted by women and by underrepresented minorities. We repeat these career stage analyses here, specifically focusing on applications received between January 8 and September 7 in six consecutive years.
OLAW Not Accepting Requests for Semiannual Facility Inspection Waivers Due to COVID-19 as of October 1, 2022
Effective October 1, 2022, the NIH Office of Laboratory Animal Welfare (OLAW) will no longer accept requests for waivers to conduct the semiannual facility inspections due to COVID-19.
In earlier posts, we looked at the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we extend on our prior analyses by presenting R01-equivalent application data on PI characteristics of Early Stage Investigators (ESIs).
It’s worth reflecting that it has been more than two years since the COVID-19 pandemic began. Let’s look back to the months of early to mid-2020 when the nation (and the rest of the world) faced a “novel” coronavirus, one which we knew could be fatal and for which there was little knowledge about how it spreads and no known effective treatment, limited diagnostic tests, and no vaccine. How did NIH make fast and meaningful contributions to respond to the pandemic?
Guidance for Applicants Preparing Applications for Summer 2022 Due Dates During the COVID-19 Pandemic
For applicants preparing applications for the summer 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch.
Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through January 2023 Councils
NIH will continue to accept a one-page update with preliminary data as post-submission materials for applications submitted for summer 2022 due dates, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application.
Our latest guest post describes the NIH Chief Officer for Scientific Workforce Diversity Office’s commitment to hold all seminars, conferences, and meetings entirely online throughout 2022. The COVID-19 pandemic-induced shift to online events has led to a growing body of research on the impact of virtual scientific convenings. A review of this literature suggests that an entirely or primarily virtual format can enhance meeting access, diversity, and climate.
Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 Pathway to Independence award. Due to ongoing disruptions caused by the COVID-19 pandemic, NIH will continue to allow up to a two-receipt cycle eligibility extension for candidates on K99/R00 applications to parent announcements. If you are planning to take advantage of this flexibility, there are a few details to keep in mind.
For Spring 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch. NIH also extended the special exception for post-submission material to applications submitted for the August/October 2022 Council rounds.